sST2 and Cardiac Surgery

Prognostic Value of sST2 in Cardiac Surgery on Long Term Morbimortality

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03887767

Enrollment

158

Registered

2019-03-25

Start date

2019-03-25

Completion date

2019-12-20

Last updated

2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Brief summary

Evaluation of the prognosis value of sST2 dosed before cardiac surgery on prognosis of long terme prognosis after cardiac surgery. The patients where initialy recruted for another cohort named micro-SIRS and inflammation but the gaved their consent to analyse the blood samples for other studies

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Age between 18 and 80 * cardiac surgery includind coronary arterial bypass of valvular surgery

Exclusion criteria

* other surgery

Design outcomes

Primary

Measure	Time frame	Description
Mortality rate	1 year	1 year mortality rate

Secondary

Measure	Time frame	Description
Number of rehospitalisation	1 day	Number of rehospitalisation
Number of cardiac events	1 day	Number of cardiac events
Number of cardiac stroke	1 day	Number of cardiac stroke

Countries

France

Outcome results